Walker_2018_Alzheimers.Res.Ther_10_51

Reference

Title : What is the impact of regulatory guidance and expiry of drug patents on dementia drug prescriptions in England? A trend analysis in the Clinical Practice Research Datalink - Walker_2018_Alzheimers.Res.Ther_10_51
Author(s) : Walker VM , Davies NM , Kehoe PG , Martin RM
Ref : Alzheimers Res Ther , 10 :51 , 2018
Abstract : Walker_2018_Alzheimers.Res.Ther_10_51
ESTHER : Walker_2018_Alzheimers.Res.Ther_10_51
PubMedSearch : Walker_2018_Alzheimers.Res.Ther_10_51
PubMedID: 29843807

Related information

Citations formats

Walker VM, Davies NM, Kehoe PG, Martin RM (2018)
What is the impact of regulatory guidance and expiry of drug patents on dementia drug prescriptions in England? A trend analysis in the Clinical Practice Research Datalink
Alzheimers Res Ther 10 :51

Walker VM, Davies NM, Kehoe PG, Martin RM (2018)
Alzheimers Res Ther 10 :51